adenocarcinoma

(redirected from endometrioid adenocarcinoma)
Also found in: Thesaurus, Medical, Encyclopedia.
?Note: This page may contain content that is offensive or inappropriate for some readers.

ad·e·no·car·ci·no·ma

 (ăd′n-ō-kär′sə-nō′mə)
n.
A malignant tumor originating in glandular tissue.

ad′e·no·car′ci·nom′a·tous (-nŏm′ə-təs, -nō′mə-təs) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

adenocarcinoma

(ˌædɪnəʊˌkɑːsɪˈnəʊmə)
n, pl -mas or -mata (-mətə)
1. (Pathology) a malignant tumour originating in glandular tissue
2. (Pathology) a malignant tumour with a glandlike structure
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ad•e•no•car•ci•no•ma

(ˌæd n oʊˌkɑr səˈnoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
1. a malignant tumor arising from secretory epithelium.
2. a malignant tumor of glandlike structure.
[1885–90]
ad`e•no•car`ci•nom′a•tous (-ˈnɒm ə təs, -ˈnoʊ mə-) adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.adenocarcinoma - malignant tumor originating in glandular epitheliumadenocarcinoma - malignant tumor originating in glandular epithelium
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
prostate cancer, prostatic adenocarcinoma - cancer of the prostate gland
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

ad·e·no·car·ci·no·ma

n. adenocarcinoma, cáncer maligno que se origina en una glándula.
English-Spanish Medical Dictionary © Farlex 2012

adenocarcinoma

n adenocarcinoma m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Endometrioid adenocarcinoma with either uterine or ovarian origin demonstrated PAX8 expression in 4 of 5 total cases (80%; Table 3).
Malignant mixed mullerian tumor with an endometrioid adenocarcinoma with a component of giant cell carcinoma: a case report and literature review.
It was followed by endometrioid adenocarcinoma 20(13.7%), mucinous cystadenocarcinoma 15(10.3%), granulosa cell tumour 15(10.3%), metastatic tumour 12(8.2%), mixed germ cell tumour 8(5.5%), yolk sac tumour 5(3.4%), mixed surface epithelial tumour 4(2.7%), dysgerminoma 4(2.7%), fibrothecoma 3(2.1%), transitional cell tumour 1(0.7%) and sertoli-stromal cell tumour 1(0.7%).
Five cases had a history of accompanying extra-appendiceal tumors (serous ovarian carcinoma, renal cell carcinoma, endometrioid adenocarcinoma, carcinoid tumor, or rectal adenocarcinoma) because these appendiceal tumors were found incidentally.
The most significant finding in our analysis was significant number of cases of endometrial endometrioid adenocarcinoma (5%).
Final pathology from her endometrial sampling was reported as FIGO grade 1, nuclear grade 1 endometrioid adenocarcinoma with squamous metaplasia.
Histologic findings were those of a carcinosarcoma with endometrioid adenocarcinoma (20%), hepatoid adenocarcinoma (20%), and sarcomatous components consisting of chondroid (10%) and spindle cell components (50%) [Figure 4].
Subtypes of endometrial cancer include the more common type I, endometrioid adenocarcinoma, and the rare type II, which encompasses clear-cell, carcinosarcomas, and endometrial serous carcinoma.
Utility of a novel Serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
Primary endometrioid adenocarcinoma of the large intestine arising in colorectal endometriosis.
This level I evidence should strongly encourage physicians to offer laparoscopic hysterectomy to patients with clinically suspected low-risk histologic types of stage I uterine endometrioid adenocarcinoma whenever technically feasible, as oncologic outcomes are equivalent up to nearly 5 years.
Among malignant diagnoses, the highest values were seen in epithelial ovarian carcinoma (endometrioid adenocarcinoma) (1427.5[+ or -]1983.44 U/mL).